Apogee Therapeutics (APGE) Income Statement (2022 - 2026)
Income Statement report data from Mar 31, 2022 to Mar 31, 2026 for Apogee Therapeutics (APGE).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||
Research And Development | 61M (+4.07%) | 58M (+7.86%) | 54M (-2.73%) | 56M (+20.07%) | 46M (-22.98%) | 60M (+31.77%) | 46M (+37.64%) | 33M (+15.63%) | 29M (-0.79%) | 29M (+69.60%) | 17M (+22.37%) | 14M (+64.89%) | 8.46M (-48.57%) | 16M (+66.33%) | 9.89M (+582.07%) | 1.45M | - |
Selling General And Administrative | 22M (+11.93%) | 20M (+14.68%) | 17M (-2.06%) | 17M (+4.49%) | 17M (+6.77%) | 16M (+20.66%) | 13M (+18.77%) | 11M (+15.31%) | 9.47M (+15.49%) | 8.20M (+13.26%) | 7.24M (+46.56%) | 4.94M (+17.62%) | 4.20M (+115.38%) | 1.95M (+214.52%) | 620K (+67.57%) | 370K | - |
Operating Expenses | 83M (+6.03%) | 78M (+9.51%) | 71M (-2.58%) | 73M (+15.96%) | 63M (-16.84%) | 76M (+29.29%) | 59M (+33.02%) | 44M (+15.56%) | 38M (+2.74%) | 37M (+52.86%) | 24M (+28.69%) | 19M (+49.21%) | 13M (-31.20%) | 18M (+75.07%) | 11M (+477.47%) | 1.82M | - |
Depreciation And Amortization | 410K (0.00%) | 410K (+2.50%) | 400K (0.00%) | 400K (+90.48%) | 210K (+31.25%) | 160K | - | - | 30K | - | - | - | - | - | - | - | - |
Operating Income | |||||||||||||||||
Operating Income | -82.77M (+6.03%) | -78.06M (+9.51%) | -71.28M (-2.58%) | -73.17M (+15.96%) | -63.10M (-16.84%) | -75.88M (+29.29%) | -58.69M (+33.02%) | -44.12M (+15.56%) | -38.18M (+2.77%) | -37.15M (+52.88%) | -24.30M (+28.64%) | -18.89M (+49.21%) | -12.66M (-31.20%) | -18.40M (+75.07%) | -10.51M (+477.47%) | -1.82M | - |
Ebit | -82.77M (+6.03%) | -78.06M (+9.51%) | -71.28M (-2.58%) | -73.17M (+15.96%) | -63.10M (-16.84%) | -75.88M (+29.29%) | -58.69M (+33.02%) | -44.12M (+15.56%) | -38.18M (+2.77%) | -37.15M (+52.88%) | -24.30M (+28.64%) | -18.89M (+49.21%) | -12.66M (-10.21%) | -14.10M (+34.16%) | -10.51M (+477.47%) | -1.82M (-57.67%) | -4.30M |
EBITDA | -82.36M (+6.08%) | -77.64M (+9.54%) | -70.88M (-2.58%) | -72.76M (+15.69%) | -62.89M (-34.28%) | -95.69M (+95.21%) | -49.02M (+44.94%) | -33.82M (-11.35%) | -38.15M (+20.23%) | -31.73M (+52.26%) | -20.84M (+10.32%) | -18.89M (+50.88%) | -12.52M (-10.64%) | -14.01M (-28.74%) | -19.66M (+980.22%) | -1.82M (-57.67%) | -4.30M |
Other Income / Expenses | |||||||||||||||||
Interest Income | 8.74M (+0.11%) | 8.73M (+38.13%) | 6.32M (-11.48%) | 7.14M (-8.93%) | 7.84M (-9.68%) | 8.68M (-10.24%) | 9.67M (-6.21%) | 10M (+69.29%) | 6.09M (+12.36%) | 5.42M (+56.20%) | 3.47M | - | 130K (+44.44%) | 90K | - | - | - |
Net Interest Income | 8.74M (+0.11%) | 8.73M (+38.13%) | 6.32M (-11.48%) | 7.14M (-8.93%) | 7.84M (-9.68%) | 8.68M (-10.24%) | 9.67M (-6.21%) | 10M (+69.29%) | 6.09M (+12.36%) | 5.42M (+56.20%) | 3.47M | - | 130K (+44.44%) | 90K | - | - | - |
Other Non Operating Income | 8.74M (-70.90%) | 30M (+375.16%) | 6.32M (-11.48%) | 7.14M (-8.93%) | 7.84M (-77.43%) | 35M (+259.26%) | 9.67M (-6.21%) | 10M (+69.29%) | 6.09M (-32.48%) | 9.02M (+159.94%) | 3.47M | - | 130K | -9.06M (-0.98%) | -9.15M | - | - |
Net Income | |||||||||||||||||
Income Before Tax | -74.03M (+6.79%) | -69.32M (+6.71%) | -64.96M (-1.61%) | -66.02M (+19.47%) | -55.26M (-17.77%) | -67.20M (+37.09%) | -49.02M (+44.94%) | -33.82M (+5.39%) | -32.09M (-61.79%) | -83.98M | - | - | - | - | - | - | - |
Income Tax Expense | 80K (+33.33%) | 60K (0.00%) | 60K (-14.29%) | 70K (-12.50%) | 80K (+300.00%) | 20K | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -74.11M (+6.80%) | -69.39M (+6.72%) | -65.02M (-1.63%) | -66.10M (+19.44%) | -55.34M (-17.67%) | -67.22M (+37.13%) | -49.02M (+44.94%) | -33.82M (+5.39%) | -32.09M (+1.13%) | -31.73M (+52.26%) | -20.84M (+10.32%) | -18.89M (+50.88%) | -12.52M (-10.64%) | -14.01M (-28.74%) | -19.66M (+980.22%) | -1.82M (-57.67%) | -4.30M |
Net Income | -74.11M (+6.80%) | -69.39M (+6.72%) | -65.02M (-1.63%) | -66.10M (+19.44%) | -55.34M (-17.67%) | -67.22M (+37.13%) | -49.02M (+44.94%) | -33.82M (+5.39%) | -32.09M (+1.13%) | -31.73M (+52.26%) | -20.84M (+10.32%) | -18.89M (+50.88%) | -12.52M (-10.64%) | -14.01M (-28.74%) | -19.66M (+980.22%) | -1.82M (-57.67%) | -4.30M |
Comprehensive Income Net Of Tax | -75.94M (-70.30%) | -255.68M (+295.30%) | -64.68M (-2.71%) | -66.48M (+20.48%) | -55.18M (-69.61%) | -181.56M (+299.38%) | -45.46M (+33.98%) | -33.93M (+4.08%) | -32.60M (-61.03%) | -83.66M (+304.15%) | -20.70M (+9.58%) | -18.89M (+50.88%) | -12.52M (-68.53%) | -39.78M (+102.34%) | -19.66M | - | - |